Press Releases
 
Primary Immunodeficiency Diseases Market to Surge at 6.1% CAGR Between 2015 and 2023

Primary Immunodeficiency Diseases Market

, 20 March 2019 -- The global primary immunodeficiency diseases market was valued at US$4.36 bn in 2014 and is estimated to reach US$7.56 bn by 2023 at a CAGR of 6.1% from 2015 to 2023.

In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North America are predominantly contributing to the growth witnessed by this market. The consistent approval of novel therapeutic options for primary immunodeficiency diseases (PIDD) and extensive research and development investments by key players are likely to bolster opportunities for the market in the forthcoming years.

Report Overview: https://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html

On the flip side, the absence of proper reimbursement and high cost of therapies will inhibit the market’s growth trajectory to an extent. Nevertheless, with favorable government policies and funding for research and development in biopharma and pharmaceuticals, growth prospects for the market seem quite promising.

Collectively accounting for a share of 79.4% in the global PIDD market, North America and Europe emerged as the dominant regional segments in 2014. Among these regions, North America boasted the largest share of 56.2% in 2014, with the U.S. at the fore. As per TMR, the U.S. held over 80.2% of the PIDD market in North America in the same year. The nation is expected to continue demonstrating lucrative opportunities for the PIDD market through the forecast period.

Over the last couple of years, a persistently increasing prevalence of diseases such as selective IgA deficiency, IgG subclass deficiency, and common variable immune deficiency has been witnessed in North America. This has fuelled the uptake of PIDD therapeutics. However, the growing awareness pertaining to side-effects such as renal failure and allergic reactions frequently associated with the treatment could hamper the market’s growth to an extent.

The primary immunodeficiency diseases market in North America, which stood at US$2.4 bn in 2014, is expected to reach US$4.3 bn by the end of 2023. The market is therefore expected to rise at a CAGR of 6.4% during the period.

Obtain the Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137

In Europe, the market is expected to gain from the increasing awareness regarding PIDD and favorable government support. The presence of companies such as Baxter International Inc., CSL Behring LLC, and Blotest Pharmaceuticals Corporation also supports the market’s expansion in the region. Apart from this, emerging nations in Asia Pacific also exhibit lucrative scope for the expansion of the PIDD market. The increasing willingness among people to spend on novel therapeutics augurs well for sales prospects of the market in Asia Pacific. The region currently holds only a moderate share in the market. However, in the near future the opportunities for sale of PIDD therapeutics in the region will increase considerably.

By treatment, stem cell and gene therapy, antibiotic therapy, immunoglobulin (Ig) replacement therapy, and others make the key segments in the global PIDD market. Of these, immunoglobulin replacement has been in use for the treatment of chronic ailments for the past two decades. Due to the recent developments, it is also used for the treatment of partial antibody deficiency and combined immunodeficiencies. The segment therefore emerged dominant in the market in 2014. As per TMR, immunoglobulin replacement therapy will hold on to its position as the market leader through the forecast period.

Despite, Ig replacement therapy being the most widely accepted treatment among PIDD patients, the use of antibiotics as an adjunct therapy is poised to surge in the near future. Some of the most commonly used antibiotics include penicillin, macrolides, cephalosporins, fluoroquinolones, and tetracyclines.

The demand for stem cell and gene therapy is also expected to increase during the forecast period, which in turn will augment the demand for effective PIDD treatment.

Request for Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3137

Some of the most prominent companies in the global primary immunodeficiency diseases market are CSL Behring LLC, Baxter International, Inc., Grifols S.A., Octapharma AG, and others.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/

# # #


Submitted by hawer on Wednesday, 20 March 2019 at 1:27 AM
Category: Health Care & Medical
 
Related News

Pulmonary Arterial Hypertension Market Is Expected To Drive By Availability Of Several Treatment Opt
Wednesday, 26 Jun 2019

Pain Management Therapeutics Market Is Expected To Drive By Rising Number Of Surgeries
Wednesday, 26 Jun 2019

Organ Preservation Solutions Market Is Expected To Drive By Increasing Technological Developments
Wednesday, 26 Jun 2019

Pulmonary Drug Delivery Devices Market is anticipated to exceed a value of US$28.7 bn by 2019
Wednesday, 26 Jun 2019

Nutraceutical Ingredients Market Is Expected To Drive By Rapidly Increasing Customer Base Across The
Wednesday, 26 Jun 2019

Related Events

2nd Combination Products Lifecycle Management 2019
Tuesday, 25 Jun 2019

ISAH 2019: 15th International Conference on SubArachnoid Hemorrhage 2019
Tuesday, 25 Jun 2019

Cell Engager Summit, June 25-27, 2019, Boston, MA
Tuesday, 25 Jun 2019

Proteome- Targeted Drug Discovery Summit 2019
Wednesday, 26 Jun 2019

4th Microbiome Movement - Drug Development Summit
Wednesday, 26 Jun 2019

Latest News

Anunita- Sustainable Fashion Design
Wednesday, 26 Jun 2019

The Potential of Core Blockchain Project SCRY.INFO
Wednesday, 26 Jun 2019

Party Enjoyable With Bounce Houses
Wednesday, 26 Jun 2019

LeoList Announces A Change In Ownership
Wednesday, 26 Jun 2019

EastShore Mining Devices Revolutionizing Cryptocurrency Mining
Wednesday, 26 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 26 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 2nd Combination Products Lifecycle Management 2019
  • Transition from IBOR to Risk Free Rates | London, 25 - 26 June 2019
  • Palo Alto Networks: Networking breakfast
  • Women of Silicon Roundabout - Join 6,000+ women in tech this June in London
  • Autonomous Ship Technology Symposium - RAI, The Netherlands

  • Latest Jobs
    Sorry, there are currently no entries posted here.